Skip to main content
GutCited

Psyllium Husk için Irritable Bowel Syndrome (IBS)

B

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpsyllium\u002Dhusk\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

Key Study Findings

Observational Study n=97
Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and …
Dose: None vs: None Outcome: IBS management heterogeneity in Latin America Etki: None None

Popülasyon: Latin American gastroenterologists (DGBI specialists)

Review
The role of dietary fiber in the gastrointestinal tract: when, how and why?
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Review of dietary fiber role in GI tract

Review
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention …
Dose: None vs: None Outcome: Colitis severity Etki: None None

Popülasyon: Ulcerative colitis patients

Randomized Controlled Trial n=314
Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain.
Dose: Dietary fiber (psyllium) vs: Low fiber diet Outcome: Abdominal pain frequency Etki: None None

Popülasyon: Children with functional abdominal pain disorders

Randomized Controlled Trial 3 weeks Double-blind
Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review …
Dose: None vs: Placebo Outcome: Pain outcomes Etki: None None

Popülasyon: IBS patients

Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others vs: Standard care or placebo Outcome: Symptom improvement in GI diseases Etki: None None

Popülasyon: Patients with gastroenterological diseases

Key Statistics

8

Çalışmalar

900

Katılımcılar

Positive

B

Derece

Referenced Papers

The Medical letter … 2025
The Medical letter … 2020
International journal of … 2017 146 atıf
Journal of gastroenterology … 2017 32 atıf
Current opinion in … 2017 24 atıf
The American journal … 2013 421 atıf
Journal of clinical … 2011 30 atıf
Alimentary pharmacology & … 2011 3 atıf
Current opinion in … 2010 22 atıf
International journal of … 2007 375 atıf
Current treatment options … 2006 24 atıf
Biomedicine & pharmacotherapy … 1986 4 atıf
Annals of internal … 1981 6 atıf
JAMA 1964

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
5-10 g/day (with adequate water)
ibssupport:
5-10 g/day (start low, titrate up over 1-2 weeks)
constipation:
10-20 g/day in divided doses with at least 240 mL water per dose

Üst sınır: Well-tolerated up to 30 g/day with adequate fluid intake

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Mixed 97
None -- Mixed --
None -- Positive --
Dietary fiber (psyllium) -- Positive 314
None 3 weeks Positive --
Peppermint oil, STW-5, psyllium, others -- Positive --
None -- Mixed --
Low-FODMAP, probiotics, fiber -- Positive --

En iyi alım zamanı: With meals and a full glass of water (240 mL minimum); space 1-2 hours from medications

Safety & Side Effects

Bildirilen Yan Etkiler

  • Gas and bloating (common initially; start with low dose and titrate up)
  • Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water)
  • Abdominal cramping at high initial doses
  • May reduce appetite (feeling of fullness)

Bilinen Etkileşimler

  • May reduce absorption of medications if taken simultaneously (space 1-2 hours)
  • Lithium (reduced absorption)
  • Carbamazepine (reduced absorption)
  • Diabetes medications (may enhance blood sugar lowering; monitor glucose)

Tolere edilebilir üst alım: Well-tolerated up to 30 g/day with adequate fluid intake

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Psyllium Husk help with Irritable Bowel Syndrome (IBS)?
Based on 8 studies with 900 participants, there is moderate evidence from clinical studies that Psyllium Husk may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Psyllium Husk should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 5-10 g/day (with adequate water). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Psyllium Husk?
Reported side effects may include Gas and bloating (common initially; start with low dose and titrate up), Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water), Abdominal cramping at high initial doses, May reduce appetite (feeling of fullness). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Psyllium Husk and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 900 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.